Evaheart
Latest round
- Series A
Last raised
- Mar 2023
Total raised
- $100M
Investors
- 3
About Evaheart
Established in 2014 and based in Chognqing, China, Evaheart is a medical device developer that focuses on the research and development of artificial heart. The company was acquired by Vivo Capital in June 2021. Evaheart has cooperated with Tokyo Women's Medical University and Waseda University. The artificial heart product has been approved by the Drug Enforcement Administration. The company focuses on the research and development of artificial heart, providing treatment before heart transplantation or heart function restore. Its artificial heart, named as Evaheart, uses the latest liquid suspension technology to achieve a physiologically pulsating blood flow imitation. Evaheart also can increase ejection during systole and decrease ejection during diastole, which maintains a 20-30 mmHg pulse pressure difference and produces pulsatile blood flow. The company also provides patients with a full life-cycle solution from prevention, diagnosis, monitoring, treatment and end-stage assistance.
Who invested in Evaheart
3 investors across 1 round
See all investors in Evaheart
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Mar 9, 2023
Amount
$100M
Investors
Questions about Evaheart
Who invested in Evaheart?
Evaheart has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Evaheart raised?
Evaheart has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Evaheart last raise money?
Evaheart's most recent round on record is a Series A, in Mar 2023.
What does Evaheart do?
Established in 2014 and based in Chognqing, China, Evaheart is a medical device developer that focuses on the research and development of artificial heart.
Where is Evaheart headquartered?
Evaheart is headquartered in Chongqing, China.
Which VCs invest in companies like Evaheart?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at Evaheart's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like Evaheart? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.